Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
$0.00
$0.01
$0.05
N/AN/A63,600 shs37,900 shs
Bally Technologies stock logo
BYI
Bally Technologies
$0.00
$56.50
$84.66
N/AN/A839,983 shsN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
$125.65
$118.17
$83.04
$125.65
N/AN/A217 shsN/A
China Media Inc. stock logo
CHND
China Media
$0.02
$0.64
$0.08
$37.00
N/AN/A425 shsN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$111.78
+0.0%
$107.02
$66.34
$119.96
$139.05B0.297.70 million shs6.96 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
0.00%0.00%0.00%0.00%0.00%
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
0.00%0.00%0.00%+13.30%+50.74%
China Media Inc. stock logo
CHND
China Media
0.00%0.00%0.00%0.00%-98.00%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%+0.55%-1.05%+5.45%+66.85%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
N/AN/AN/AN/AN/AN/AN/AN/A
China Media Inc. stock logo
CHND
China Media
N/AN/AN/AN/AN/AN/AN/AN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4.8399 of 5 stars
1.43.04.24.14.02.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
0.00
N/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
0.00
N/AN/AN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
0.00
N/AN/AN/A
China Media Inc. stock logo
CHND
China Media
0.00
N/AN/AN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.78
Moderate Buy$110.55-1.10% Downside

Current Analyst Ratings Breakdown

Latest GILD, AMEFF, BYI, CHND, and CEVMF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$130.00 ➝ $135.00
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$132.00 ➝ $125.00
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/22/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$125.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/AN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
N/AN/AN/AN/AN/AN/A
China Media Inc. stock logo
CHND
China Media
N/AN/AN/AN/AN/AN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$28.75B4.84$6.87 per share16.27$15.44 per share7.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
N/AN/A0.00N/AN/AN/AN/A8/21/2025 (Estimated)
China Media Inc. stock logo
CHND
China Media
N/AN/A0.00N/AN/AN/AN/AN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$480M$4.7523.5313.780.7220.76%51.93%17.40%8/6/2025 (Estimated)

Latest GILD, AMEFF, BYI, CHND, and CEVMF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025Q1 2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.77$1.81+$0.04$1.04$6.77 billion$6.67 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/AN/AN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
N/AN/AN/AN/AN/A
China Media Inc. stock logo
CHND
China Media
N/AN/AN/AN/AN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.162.83%N/A66.53%10 Years

Latest GILD, AMEFF, BYI, CHND, and CEVMF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.793%6/13/20256/13/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/A
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/A
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
N/AN/AN/A
China Media Inc. stock logo
CHND
China Media
N/AN/AN/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1.16
1.37
1.23
CompanyEmployeesShares OutstandingFree FloatOptionable
Appreciated Media Holdings Inc. stock logo
AMEFF
Appreciated Media
N/AN/AN/ANot Optionable
Bally Technologies stock logo
BYI
Bally Technologies
N/AN/AN/ANot Optionable
CTS Eventim AG & Co. KGaA stock logo
CEVMF
CTS Eventim AG & Co. KGaA
3,836N/AN/ANot Optionable
China Media Inc. stock logo
CHND
China Media
4N/AN/ANot Optionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,6001.24 billion1.24 billionOptionable

Recent News About These Companies

GILD - Gilead Sciences Inc Financials - Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

Appreciated Media stock logo

Appreciated Media OTCMKTS:AMEFF

Appreciated Media Holdings, Inc. is a worldwide film and television media production packager. It engages in producing independent films, made-for-television movies, and TV series for global B2B distribution. The company was founded by Kirk Edward Shaw, Tony Zhang, and Norman Tsui on October 1, 2014 and is headquartered in Hamilton, Canada.

Bally Technologies stock logo

Bally Technologies NYSE:BYI

Bally Technologies, Inc. (Bally) is a global gaming company, which designs, manufactures, operates, and distributes advanced technology-based gaming devices, systems, server-based solutions, custom mobile applications, and interactive applications. The Company also provides hardware, including spinning-reel and video gaming devices, specialty gaming devices, and wide-area progressive systems. The Company supports customers include land-based, riverboat, and Native American casinos, video lottery and central determination markets. The Company derives its revenue from sale of gaming devices and related equipment, parts and conversion kits; operation of linked progressive systems, video lottery and centrally determined systems, and the rental of gaming devices and content, and sale and support of specialized systems-based software, hardware and interactive products and related recurring maintenance revenue. In July 2014, Bally Technologies Inc acquired Dragonplay Ltd. (Dragonplay).

CTS Eventim AG & Co. KGaA stock logo

CTS Eventim AG & Co. KGaA OTCMKTS:CEVMF

$125.65 0.00 (0.00%)
As of 07/3/2025

CTS Eventim AG & Co. KGaA operates in the leisure events market in Germany, Italy, the United States, Switzerland, Austria, the United Kingdom, Sweden, Finland, Spain, Brazil, Denmark, the Netherlands, and internationally. The company operates through two segments, Ticketing and Live Entertainment. The Ticketing segment produces, sells, brokers, distributes, and markets tickets for concerts, festival, theatre, musicals, trade fairs, art, cinema, exhibitions, edutainment, sports, and other events. It markets event tickets through stationary and online distribution EVENTIM.Net; inhouse ticketing product for classical music and theatre through EVENTIM.Inhouse; sport ticketing products through EVENTIM.Tixx; and self-service products for promotors through EVENTIM.Light, as well as provides a solution for ticket sales and admission control through EVENTIM.Access. This segment also operates kinoheld software for cinema operators. The Live Entertainment segment plans, prepares, and performs tours, events, and festivals, including music events and concerts, as well as markets music productions. This segment is also involved in the operation of venues. The company was formerly known as CTS EVENTIM AG and changed its name to CTS Eventim AG & Co. KGaA in May 2014. CTS Eventim AG & Co. KGaA was founded in 1989 and is headquartered in Bremen, Germany.

China Media stock logo

China Media NASDAQ:CHND

China Media Inc., through its subsidiaries, produces and distributes films, television series, and documentaries in China. The company sells television series to regional and national television stations. It distributes its films and television series through direct sales channel. The company was formerly known as Protecwerx Inc. China Media Inc. was incorporated in 2007 and is based in Xi'an, China.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$111.78 +0.03 (+0.03%)
Closing price 04:00 PM Eastern
Extended Trading
$112.24 +0.46 (+0.41%)
As of 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.